POAI New LOGO.jpg
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
March 28, 2024 17:28 ET | Predictive Oncology Inc.
PITTSBURGH, March 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
POAI New LOGO.jpg
Predictive Oncology to Participate in Upcoming Investor Conferences
February 21, 2024 16:05 ET | Predictive Oncology Inc.
PITTSBURGH, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive...
POAI New LOGO.jpg
Predictive Oncology to Participate in Upcoming San Francisco Conferences
January 02, 2024 07:00 ET | Predictive Oncology Inc.
PITTSBURGH, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive...
POAI New LOGO.jpg
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023 07:00 ET | Predictive Oncology Inc.
PITTSBURGH, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
POAI New LOGO.jpg
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
November 08, 2023 08:12 ET | Predictive Oncology Inc.
PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study...
POAI New LOGO.jpg
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
November 07, 2023 07:00 ET | Predictive Oncology Inc.
PITTSBURGH, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
POAI New LOGO.jpg
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023 17:15 ET | Predictive Oncology Inc.
PITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
POAI New LOGO.jpg
Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
August 03, 2023 08:00 ET | Predictive Oncology Inc.
EAGAN, Minn., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
POAI New LOGO.jpg
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
July 18, 2023 08:00 ET | Predictive Oncology Inc.
Surrounded by world renowned universities and medical centers,Predictive Oncology is part of the next generation of Pittsburgh’s innovation ecosystem PITTSBURGH, July 18, 2023 (GLOBE NEWSWIRE) --...
POAI New LOGO.jpg
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
June 27, 2023 08:00 ET | Predictive Oncology Inc.
EAGAN, Minn., June 27, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...